Investment

Medical technology provides one of Scotland's strongest commercial bases representing 40 percent of our life sciences companies. 

Those targeting medtech markets are well supported by specialist providers of:

• Intellectual property
• Legal services
• Regulatory affairs
• Product design and manufacturing

Investment potential and opportunities

The maturity of Scotland's medtech sector makes it the ideal location for potential investors. Emerging opportunities lie in areas such as assisted living and telehealth with the growth of applications for remote diagnosis, treatment, monitoring and management of chronically ill and elderly patients.

Stratified medicine plays to Scotland's strengths in the evolution of next generation diagnostics for drug development and patient stratification.

• Speed the development of your diagnostic by accessing cross-disciplinary medtech expertise in a collaborative environment 
• Advance your diagnostics development by tapping into Scotland’s depth of expertise in convergent technologies – including nanotechnology, photonics, microelectronics, and wellness technology 
• Speed your diagnostic through regulatory approval supported by Scotland’s significant clinical expertise 
• Benefit from Scotland’s unique and extensive pharma services and contract research organisations 
• Take advantage of our support to help get your product to market

Support for research commercialisation

World-leading medical technology research and development is carried out in Scotland, backed by government support available for the commercialisation of research leading to further opportunities including:

• Provision of manufacturing capability to support the existing clinical research organisation base
• Ease of access to European and global markets 
• Scotland’s diversity of research to tap into including radiography, bioengineering, biomaterials and biophotonics

Benefits of investing in Scotland

These include access to: 

• A highly skilled workforce − more than 640 life science organisations employ over 32,000 staff in Scotland 
• A thriving well-established life sciences hub − collaboration between academia, industry and other parties has resulted in a thriving, growing industry making exciting new discoveries 
• Supportive life science community − access to almost 60 university and research facilities, 11,000 research staff and a strong research network worldwide 
• An effective supply chain − 80 percent of Scotland’s life sciences industry is located around Edinburgh, Dundee and Glasgow, and this proximity of sites enables a more efficient supply chain 
• Groundbreaking research and development − Scotland has led to the discovery and application of many scientific innovations in several areas of life sciences 
• Scotland’s extensive knowledge base − attracts around £350 million of life sciences research funding annually

Contact us for more details about investing in Scotland's medtech sector